This study is the first to assess the prognostic role of soluble and EV-associated B7-H3 and B7-H4, together with the already known role of PD-L1, in a cohort of advanced NSCLC patients treated with ICIs in first and second-line settings. The gene discussed is CD276; the disease is non-small cell lung carcinoma.